Acute Myeloid Leukemia Treatment Options Expand With Recent FDA Approvals

Leukemia: Signs - Symptoms - Diagnosis

FDA Expands Approval of Imbruvica® to Include Initial Treatment for Chronic Lymphocytic Leukemia & Small Cell Lymphoma

FDA Approves Precision Medicine Enasidenib as new Targeted Treatment for individuals with AML and IDH2 genetic mutation

Stay Current With Leukemia Treatment Advances & Connect with Others

American Society Hematology Meeting update continues to show superiority of Venclexta for Chronic Lymphocytic Leukemia

Trisonex (arsenic) has become an effective and standard treatment for all phases of acute promyelocytic leukemia.